Multiple microRNAs act as negative regulators of IMP2 across a variety of biological processes and diseases, including breast, pancreatic, and hepatocellular carcinoma, as well as keratinocyte migration, demonstrating the extensive regulatory network controlling its activity [55,56,57,58,59,60,61]. This evidence concerns the gene IGF2BP2 and hepatocellular carcinoma.